427
Views
6
CrossRef citations to date
0
Altmetric
Review

The Changing Global Epidemic of HIV and Ocular Disease

, MD, PhD, , MD, PhD, , MD, PhD & , MD, PhD
Pages 1007-1014 | Received 19 Dec 2019, Accepted 31 Mar 2020, Published online: 12 May 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Birhanu Belete Aragaw, Haile Woretaw Alemu, Aragaw Kegne Assaye, Yared Ayelign Belete & Henok Biruk Alemayehu. (2023) Prevalence and Associated Factors of Ocular Manifestations of Acquired Immune Deficiency Syndrome Among Adults at University of Gondar Hospital, North West Ethiopia, 2021. Clinical Ophthalmology 17, pages 1323-1333.
Read now
Ebru Esen, Selcuk Sizmaz, Ferit Kuscu, Cansu Demircan, Yesim Tasova, Ilker Unal & Nihal Demircan. (2023) Analysis of Macular Microvasculature in Human Immunodeficiency Virus Infection. Ocular Immunology and Inflammation 31:4, pages 728-733.
Read now
Ritu Arora, Neha Sandhu, Pallavi Dokania & Anuradha Subramanian. (2022) Ocular Manifestations in Patients of HIV(Human Immunodeficiency Virus) Infection on Combined Anti-Retroviral Therapy (CART). Ocular Immunology and Inflammation 30:6, pages 1399-1407.
Read now
Emmett T Cunningham$suffix/text()$suffix/text() & Manfred Zierhut. (2020) HIV/AIDS and the Eye. Ocular Immunology and Inflammation 28:7, pages 1005-1006.
Read now

Articles from other publishers (2)

Serisha Jay Narain, Linda Visser & Wilbert Sibanda. (2022) Cytomegalovirus retinitis and antiretroviral treatment: A fifteen year experience. Southern African Journal of HIV Medicine 23:1.
Crossref
Shery Jacob, Anroop B. Nair, Jigar Shah, Sumeet Gupta, Sai H. S. Boddu, Nagaraja Sreeharsha, Alex Joseph, Pottathil Shinu & Mohamed A. Morsy. (2022) Lipid Nanoparticles as a Promising Drug Delivery Carrier for Topical Ocular Therapy—An Overview on Recent Advances. Pharmaceutics 14:3, pages 533.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.